Rein Therapeutics
RNTX
#10167
Rank
NZ$0.11 B
Marketcap
NZ$1.37
Share price
-1.15%
Change (1 day)
-30.04%
Change (1 year)

Earnings for Rein Therapeutics (RNTX)

Earnings in 2026 (TTM): -NZ$36.68 Million

According to Rein Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$38.4 Million, an increase over its 2024 earnings that were of -NZ$49.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rein Therapeutics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$36.68 Million-4.49%
2025 -NZ$38.4 Million-21.99%
2024 -NZ$49.23 Million83.16%
2023 -NZ$26.88 Million-44.49%
2022 -NZ$48.41 Million3.92%
2021 -NZ$46.59 Million29.81%
2020 -NZ$35.89 Million-31.58%
2019 -NZ$52.45 Million-6.1%
2018 -NZ$55.86 Million38.66%
2017 -NZ$40.29 Million26.63%
2016 -NZ$31.82 Million